Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg‐Negative Chronic Hepatitis B-Reference-Cited by-同舟云学术

Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg‐Negative Chronic Hepatitis B

Published:2021-06-18 Issue:10 Volume:5 Page:1632-1648
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Bömmel Florian¹^ORCID,Berg Thomas¹

Affiliation:

1. Division of Hepatology Department of Medicine II Leipzig University Medical Center Leipzig Germany

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1708

Reference89 articles.

1. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection

2. Hepatitis B virus infection

3. Inhibition of hepatitis B virus gene expression: A step towards functional cure

4. Long term treatment with tenofovir disoproxil fumarate for chronic hepatitis B infection is safe and well tolerated and associated with durable virologic response with no detectable resistance: 8 year results from two phase 3 trials;Marcellin P;Hepatology,2014

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2;Journal of Hepatology;2024-09

2. Discontinuation of Nucleos(t)ide Analogues in HBeAg Negative Chronic Hepatitis B Patients: Risks and Benefits;Infectious Diseases and Clinical Microbiology;2024-06-28

3. Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B Using HBsAg Thresholds: A Meta-Analysis and Meta-Regression;Clinical Gastroenterology and Hepatology;2024-06

4. Predictors of Nucleos(t)ide Analogues Discontinuation Relapse: Hepatitis B Virus RNA versus Hepatitis B Surface Antigen;Journal of the College of Physicians and Surgeons Pakistan;2024-05-01

5. Evaluation of chronic hepatitis B patients who voluntarily discontinued oral antiviral therapy: is there an answer to the controversial topic?;European Journal of Gastroenterology & Hepatology;2024-02-23